Global Insights: Regenerative Medicine For Cartilage Market Expected to Surpass $5.97 Billion by 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Regenerative Medicine For Cartilage Sector?
In the recent past, there has been notable growth in the market size of regenerative medicine for cartilage. It is projected to grow from $4.43 billion in 2024 to $4.68 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. The considerable growth during the historical period can be explained by the growth of the regenerative medicine market driven by increasing chronic disease prevalence, growth in emerging markets, enforcement of the 21st century cures act, a rising aged population, and improvements in healthcare awareness and spending.
Anticipated strong growth is predicted for the regenerative medicine for cartilage market, expected to increase to “$5.97 billion by 2029 at an annual compound growth rate of 6.3%. This growth can be traced back to factors such as a surge in the demand for organ transplants, increased spending in healthcare, advancements in regenerative medicine technology, escalated investiture in regenerative medicine, and shifting lifestyles. Key trends during the forecast period encompass increased utilization of mesenchymal stem cell technology, rise in research & development on the application of novel gene therapy techniques, progress in technology transfer and clinical translation, an increment in strategic collaborations, partnerships and agreements, emergence and growth of new companies, the role of injectable hydrogel in cartilage repair as a regenerative medicine and international research initiatives and funding.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3961&type=smp
What Forces Are Driving The Growth Of The Regenerative Medicine For Cartilage Market?
The market for regenerative medicine for cartilage is predicted to expand due to the rising occurrence of osteoarthritis worldwide. Osteoarthritis is a type of degenerative joint disease primarily affecting the articular cartilage. The Arthritis Foundation has stated that by 2050, degenerative joint diseases like osteoarthritis are anticipated to affect a minimum of 130 million people globally. Autologous chondrocyte implantation and scaffold implants are among the most commonly employed treatments for osteoarthritis. As such, the growing prevalence of osteoarthritis is likely to stimulate the demand in the market for regenerative medicine for cartilage.
The regenerative medicine for cartilage market covered in this report is segmented –
1) By Product: Cell Based, Gene Based, Tissue Based
2) By End-Use: Ambulatory Surgical Centers, Hospitals And Clinics, Others
3) By Application: Musculoskeletal, Oncology, Dental, Wound Care, Others
Subsegments:
1) By Cell-Based: Chondrocyte-Based Therapies, Mesenchymal Stem Cell (MSC) Therapies, Induced Pluripotent Stem Cell (iPSC) Therapies, Embryonic Stem Cell (ESC) Therapies
2) By Gene-Based: Gene Modification Therapies, CRISPR-Based Gene Editing, Viral Vector Gene Therapies, Non-Viral Gene Therapies
3) By Tissue-Based: Autologous Tissue Grafts, Allogeneic Tissue Grafts, Xenogeneic Tissue Grafts, Synthetic Scaffolds
What Long-Term Trends Are Likely To Affect The Regenerative Medicine For Cartilage Market?
Emerging developments in the regenerative medicine for the cartilage market are being shaped by the rising relevance of tissue engineering and stem cell therapy. Tissue engineering has been growing, providing promising prospects for cartilage regeneration. Meanwhile, stem cell therapy, with its merits over orthodox orthopedic methods, is increasingly recognizing. It aids in lessening knee pain and boosts the regeneration and repair of knee cartilage. Growth factors, such as platelet-rich plasma (PRP) therapy, are being utilized to stimulate effective tissue regeneration, for example. Businesses in the market are persistently centered on launching fresh technologies to maintain competitiveness in the regenerative medicine for the cartilage market.
Which Companies Currently Dominate The Competitive Landscape In The Regenerative Medicine For Cartilage Industry?
Major companies operating in the regenerative medicine for cartilage market include Smith & Nephew plc, Integra LifeSciences, Stryker Corporation, MiMedx Group, Inc., Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, AbbVie, CONMED Corporation, Arthrex Inc., Baxter International Inc., China Regenerative Medicine International, AstraZenaca, ABLbio, Cellgenix Gmbh, BioTissue Technologies, Corin Group, Medical Import Ltd., Orthonika, Merete, 3di GmbH, Aditus Medical GmbH, Anton Hipp GmbH, AREX SAS, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc, Organogenesis Inc, NuVasive, Inc, Japan Tissue Engineering Co., Ltd, Advantagene, Inc., Mesoblast Ltd, Globus Medical, DePuy Synthes, Cryolife Inc, Johnson & Johnson, Medtronic Plc, Rti Surgical, CartiHeal, Inc., DJO Global Inc., Wright Medical Group, Auxein, Aesculap, Inc, AMEGA Biotech
Which Geographic Regions Are Driving Demand In The Regenerative Medicine For Cartilage Market?
Europe was the largest region in regenerative medicine for cartilage in 2024. The regions covered in the regenerative medicine for cartilage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=3961&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
